Prevention of ischaemic heart disease in the hypertensive patient.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000209:etiology; D001161:Arteriosclerosis / Q000209:etiology / Q000503:physiopathology; D006332:Cardiomegaly / Q000209:etiology / Q000503:physiopathology; D003326:Coronary Circulation; D003327:Coronary Disease / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D003645:Death, Sudden / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D013599:Systole / Q000187:drug effects
D000319:Adrenergic beta-Antagonists